EUVIMEDEUVIMED entdecken
Crossref

TCT-22 Long-Term Antiplatelet Monotherapy After PCI in Acute Coronary Syndrome: Clopidogrel Versus Aspirin

Hao-Yu Wang, Jiaxi Cheng, Kefei Dou

JACC · 2026-11 · 88 (18) · B9

DOI: 10.1016/j.jacc.2026.09.062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-11. Verfasst von Hao-Yu Wang und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wang, H., Cheng, J., & Dou, K. (2026). TCT-22 Long-Term Antiplatelet Monotherapy After PCI in Acute Coronary Syndrome: Clopidogrel Versus Aspirin. JACC, 88(18), B9. https://doi.org/10.1016/j.jacc.2026.09.062

Vancouver

Wang H, Cheng J, Dou K. TCT-22 Long-Term Antiplatelet Monotherapy After PCI in Acute Coronary Syndrome: Clopidogrel Versus Aspirin. JACC. 2026;88(18):B9. doi:10.1016/j.jacc.2026.09.062

BibTeX
@article{Wang2026,
  author = {Wang, Hao-Yu and Cheng, Jiaxi and Dou, Kefei},
  title = {TCT-22 Long-Term Antiplatelet Monotherapy After PCI in Acute Coronary Syndrome: Clopidogrel Versus Aspirin},
  journal = {JACC},
  year = {2026},
  volume = {88},
  number = {18},
  pages = {B9},
  doi = {10.1016/j.jacc.2026.09.062}
}
Kostenlos starten →